Startle disease in Irish wolfhounds associated with a microdeletion in the glycine transporter GlyT2 gene

Neurobiology of Disease

Volumn 43, Issue 1, 2011, Pages 184-189

  Gill, Jennifer L ^a   Capper, Deborah ^b   Vanbellinghen, Jean François ^c   Chung, Seo Kyung ^d   Higgins, Robert J ^e   Rees, Mark I ^d   Shelton, G Diane ^f   Harvey, Robert J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b Halsey East Animal Clinic   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d SWANSEA UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glycine transporter; GlyT2; Hyperekplexia; Irish wolfhound; SLC6A5; Startle disease

Indexed keywords

GENOMIC DNA; GLYCINE RECEPTOR; GLYCINE RECEPTOR ALPHA1 SUBUNIT; GLYCINE RECEPTOR BETA SUBUNIT; GLYCINE TRANSPORTER 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CARE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DOG; EXON; FEMALE; FRAMESHIFT MUTATION; GENE; GENE DELETION; GENE MICRODELETION; GENETIC ASSOCIATION; GENOME SIZE; GENOTYPE; GLYCINE TRANSPORTER 2 GENE; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOTE; HYPEREKPLEXIA; IRISH WOLFHOUND; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUSCLE STIFFNESS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SOUTHERN BLOTTING; TREMOR;

ANIMALS; BASE SEQUENCE; DOG DISEASES; DOGS; EPILEPSY, REFLEX; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MOLECULAR SEQUENCE DATA; MUSCLE TONUS; PEDIGREE; STARTLE REACTION; TREMOR;

EID: 79955975154     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.03.010     Document Type: Article

References (27)

1. Bakker M.J., Peeters E.A., Tijssen M.A. Clonazepam is an effective treatment for hyperekplexia due to a SLC6A5 (GlyT2) mutation. Mov. Disord. 2009, 24:1852-1854.
2. Ball E.V., Stenson P.D., Abeysinghe S.S., Krawczak M., Cooper D.N., Chuzhanova N.A. Microdeletions and microinsertions causing human genetic disease: common mechanisms of mutagenesis and the role of local DNA sequence complexity. Hum. Mutat. 2005, 26:205-213.
3. Becker K., Hohoff C., Schmitt B., Christen H.J., Neubauer B.A., Sandrieser T., Becker C.M. Identification of the microdeletion breakpoint in a GLRA1 null allele of Turkish hyperekplexia patients. Hum. Mutat. 2006, 27:1061-1062.
4. Brune W., Weber R.G., Saul B., von Knebel Doeberitz M., Grond-Ginsbach C., Kellerman K., Meinck H.M., Becker C.M. A GLRA1 null mutation in recessive hyperekplexia challenges the functional role of glycine receptors. Am J Hum Genet 1996, 58:989-997.
5. Charlier C., Coppieters W., Rollin F., Desmecht D., Agerholm J.S., Cambisano N., Carta E., Dardano S., Dive M., Fasquelle C., Frennet J.C., Hanset R., Hubin X., Jorgensen C., Karim L., Kent M., Harvey K., Pearce B.R., Simon P., Tama N., Nie H., Vandeputte S., Lien S., Longeri M., Fredholm M., Harvey R.J., Georges M. Highly effective SNP-based association mapping and management of recessive defects in livestock. Nat. Genet. 2008, 40:449-454.
6. Chung S.K., Vanbellinghen J.F., Mullins J.G., Robinson A., Hantke J., Hammond C.L., Gilbert D.F., Freilinger M., Ryan M., Kruer M.C., Masri A., Gurses C., Ferrie C., Harvey K., Shiang R., Christodoulou J., Andermann F., Andermann E., Thomas R.H., Harvey R.J., Lynch J.W., Rees M.I. Pathophysiological mechanisms of dominant and recessive GLRA1 mutations in hyperekplexia. J. Neurosci. 2010, 30:9612-9620.
7. Dubowitz V., Sewry C.A. Histological and histochemical stains and reactions. Muscle Biopsy: A Practical Approach 2007, 21-39. Saunders Elsevier, Philadelphia USA. 3rd ed. V. Dubowitz, C.A. Sewry (Eds.).
8. Eulenburg V., Becker K., Gomeza J., Schmitt B., Becker C.M., Betz H. Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia. Biochem. Biophys. Res. Commun. 2006, 348:400-405.
9. Fox J.G., Averill D.R., Hallett M., Schunk K. Familial reflex myoclonus in Labrador Retrievers. Am. J. Vet. Res. 1984, 45:2367-2370.
10. Gill J.L., James V.M., Carta E., Topf M., Scholes S.F.E., Hateley G., Harvey R.J. Identification of congenital muscular dystonia 2 associated with an inherited GlyT2 defect in Belgian Blue cattle in the United Kingdom. Anim. Genet. 2011, Submitted.
11. Gomeza J., Ohno K., Hülsmann S., Armsen W., Eulenburg V., Richter D.W., Laube B., Betz H. Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 2003, 40:797-806.
12. Gundlach A.L. Disorder of the inhibitory glycine receptor: inherited myoclonus in Poll Hereford calves. FASEB J. 1990, 4:2761-2766.
13. Gundlach A.L., Dodd P.R., Grabara C.S., Watson W.E., Johnston G.A., Harper P.A., Dennis J.A., Healy P.J. Deficit of spinal cord glycine/strychnine receptors in inherited myoclonus of Poll Hereford calves. Science 1988, 241:1807-1810.
14. Gundlach A.L., Kortz G., Burazin T.C., Madigan J., Higgins R.J. Deficit of inhibitory glycine receptors in spinal cord from Peruvian Pasos: evidence for an equine form of inherited myoclonus. Brain Res. 1993, 628:263-270.
15. Harper P.A., Healy P.J., Dennis J.A. Inherited congenital myoclonus of polled Hereford calves (so-called neuraxial oedema): a clinical, pathological and biochemical study. Vet. Rec. 1986, 119:59-62.
16. Harvey R.J., Topf M., Harvey K., Rees M.I. The genetics of hyperekplexia: more than startle!. Trends Genet. 2008, 24:439-447.
17. Herrtage M.E., Palmer A.C. Episodic falling in the cavalier King Charles spaniel. Vet. Rec. 1983, 112:458-459.
18. Lummis S.C., Gundlach A.L., Johnston G.A., Harper P.A., Dodd P.R. Increased γ-aminobutyric acid receptor function in the cerebral cortex of myoclonic calves with an hereditary deficit in glycine/strychnine receptors. J. Neurochem. 1990, 55:421-426.
19. Manzke T., Niebert M., Koch U.R., Caley A., Vogelgesang S., Hülsmann S., Ponimaskin E., Müller U., Smart T.G., Harvey R.J., Richter D.W. Serotonin receptor 1A-modulated phosphorylation of glycine receptor α3 controls breathing in mice. J. Clin. Invest. 2010, 120:4118-4128.
20. Pierce K.D., Handford C.A., Morris R., Vafa B., Dennis J.A., Healy P.J., Schofield P.R. A nonsense mutation in the α1 subunit of the inhibitory glycine receptor associated with bovine myoclonus. Mol. Cell. Neurosci. 2001, 17:354-363.
21. Rees M.I., Harvey K., Pearce B.R., Chung S.K., Duguid I.C., Thomas P., Beatty S., Graham G.E., Armstrong L., Shiang R., Abbott K.J., Zuberi S.M., Stephenson J.B., Owen M.J., Tijssen M.A., van den Maagdenberg A.M., Smart T.G., Supplisson S., Harvey R.J. Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat. Genet. 2006, 38:801-806.
22. Rees M.I., Lewis T.M., Kwok J.B., Mortier G.R., Govaert P., Snell R.G., Schofield P.R., Owen M.J. Hyperekplexia associated with compound heterozygote mutations in the β-subunit of the human inhibitory glycine receptor (GLRB). Hum. Mol. Genet. 2002, 11:853-860.
23. Rousseau F., Aubrey K.R., Supplisson S. The glycine transporter GlyT2 controls the dynamics of synaptic vesicle refilling in inhibitory spinal cord neurons. J. Neurosci. 2008, 28:9755-9768.
24. Schouten J.P., McElgunn C.J., Waaijer R., Zwijnenburg D., Diepvens F., Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002, 30:e57.
25. Shiang R., Ryan S.G., Zhu Y.Z., Fielder T.J., Allen R.J., Fryer A., Yamashita S., O'Connell P., Wasmuth J.J. Mutational analysis of familial and sporadic hyperekplexia. Ann. Neurol. 1995, 38:85-91.
26. Shiang R., Ryan S.G., Zhu Y.Z., Hahn A.F., O'Connell P., Wasmuth J.J. Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat. Genet. 1993, 5:351-358.
27. Southern E. Southern blotting. Nat. Protoc. 2006, 1:518-525.